News & Views
MorphoSys Appoints New Head of Research Antibody Business
Mar 17 2009
MorphoSys AG (Martinsreid/Munich) has appointed Dieter Feger to head its AbD Serotec business for research and diagnostic antibodies. He joins the company from Abbott Diagnostics, where he was of Marketing Director - Global Marketing for the past four years most recently with
responsibility for Infectious Diseases, Abbott Diagnostics’ biggest reagent franchise. Prior to that, he spent 18 years with Abbott in Europe, in a variety of roles before moving to the US. He replaces Dieter Lingelbach who has left MorphoSys to pursue new opportunities.
"I am delighted to welcome Dieter Feger to the management team of MorphoSys. He brings deep experience from his work at Abbott Diagnostics, one of the industry’s leading companies, that will assist AbD Serotec to seek new growth opportunities and to expand its footprint in the diagnostics industry," commented Dr Simon Moroney, Chief Executive Officer of MorphoSys AG. "I would like to thank Dieter Lingelbach for his
invaluable contribution to establishing AbD Serotec as a leading supplier of research antibodies and wish him well in the future."
Digital Edition
International Labmate 49.6 - Sept 2024
September 2024
Chromatography Articles - HPLC gradient validation using non-invasive flowmeters Mass Spectrometry & Spectroscopy Articles - From R&D to QC, making NMR accessible for everyone: Putting NMR...
View all digital editions
Events
Oct 30 2024 Birmingham, UK
Oct 30 2024 Manchester, UK
Nov 11 2024 Dusseldorf, Germany
Nov 12 2024 Cologne, Germany
Nov 12 2024 Tel Aviv, Israel